Anticoagulants may prolong lives of prostate cancer patients

02/22/2013 | HealthDay News

Researchers tracked nearly 250 patients with advanced or spreading prostate cancer and found a 39% increase in survival among those treated with anticoagulants. Because of bleeding risks, the drugs should be used carefully, experts cautioned. The study examined patients being treated with chemotherapy and was reported at a meeting of the American Society of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX